PODD - Insulet公司
收市後：
| 前收市價 | 281.03 |
| 開市 | 283.22 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 280.55 - 287.80 |
| 52 週波幅 | 192.33 - 335.91 |
| 成交量 | |
| 平均成交量 | 927,709 |
| 市值 | 19.798B |
| Beta 值 (5 年，每月) | 0.79 |
| 市盈率 (最近 12 個月) | ∞ |
| 每股盈利 (最近 12 個月) | 0.00 |
| 業績公佈日 | 2023年8月02日 - 2023年8月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 354.29 |
Insider MonkeyShould You Invest in Insulet Corporation (PODD)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returned 5.43% in the quarter compared to a 6.90% return for the Russell Midcap Growth Index. For the full year, the fund […]
Insider MonkeyMultiple Reasons for the Outperformance of Insulet Corporation (PODD) in Q4
Alger Capital, an investment management company, released its “Alger Mid Cap Focus Fund” fourth quarter investor letter. A copy of the same can be downloaded here. Class Z of the Mid-cap growth fund returned 0.77% in the fourth quarter compared to the 6.90% gain for the Russell Midcap Growth Index. The Utilities and Communication sectors contributed […]
Insider MonkeyShould You Hold Insulet Corporation (PODD)?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed the Russell 2500 Growth benchmark. On an absolute basis, the strategy gained in nine of the 10 sectors it was invested in […]
InvestorPlaceThe 7 Best Tech Stocks to Buy for February 2023
Tech stocks continue to be a major player in the stock market in 2023. Driven by ongoing innovation and investment, big-name turnarounds suggest that Feb. could be the beginning of a sharp upward trend for tech stocks. In fact, here are seven of the best tech stocks to consider for the year. PI Impinj $126.80 META Meta Platforms $178.17 PODD Insulet Corporation $286.67 MSFT Microsoft $264.03 STX Seagate Technology $69.43 CRM Salesforce $172.56 NFLX Netflix $362.79 Best Tech Stocks: Impinj (PI) S
Insider Monkey15 Biggest Medical Device Companies in the World
In this article, we will take a look at the 15 biggest medical device companies in the world. If you want to skip our introduction to the industry, then take a look at 5 Biggest Medical Device Companies in the World. The medical device market comprises companies that manufacture equipment used in diagnosing, treating and surveillance […]
BenzingaInsulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
Insulet Corporation (NASDAQ: PODD) announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. Insulet has received 24 reports that the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) is melting, deforming or discoloring due to heat generated by a poor connection between the cable and the port. Related: Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved
BenzingaInsulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance
Insulet Corp (NASDAQ: PODD) posted an adjusted EPS of $0.45 in Q3, surpassing the consensus of $0.15. Insulet recorded a bottom-line dip into the red of $(5.2) million from profits of $12.6 million a year ago. However, the company registered sales growth of 23.7% Y/Y to $340.8 million, beating the consensus of $312.52 million. The company reported total Omnipod automated insulin delivery system revenue of $326.1 million. Insulet initiated the full market launch of the latest-generation Omnipod 5
Insider Monkey10 Best Diabetes Stocks To Buy Now
In this article, we discuss the 10 best diabetes stocks to buy now. If you want to read about some more diabetes stocks, go directly to 5 Best Diabetes Stocks To Buy Now. The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant […]
BenzingaFDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above
The FDA has cleared Insulet Corporation's (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes (T1D). Omnipod 5 is tubeless automated insulin delivery (AID) system in the U.S. that was initially cleared for use in individuals aged six and older in January 2022. Also Read: Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance. In a recent publication by Sherr et al. in Diabetes Care, Omnipod 5 significantly improved time in range an
Insider Monkey10 Healthcare Stocks Making Moves After Earnings
In this article, we will take a look at the 10 healthcare stocks making moves after earnings. If you want to see some more healthcare companies moving on quarterly results, go directly to 5 Healthcare Stocks Making Moves After Earnings. The Healthcare sector is usually considered defensive. That’s because pharmaceutical companies, hospitals, medical device makers […]
BenzingaInsulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
Insulet Corporation (NASDAQ: PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37) a year ago. Q2 sales increased 13.8% Y/Y, or 17.7% in constant currency, to $299.4 million, exceeding the guidance range of 12%-15% in constant currency and the consensus of $291.45 million. Total Omnipod automated insulin delivery system revenue was $285.8 million, +18.1%. Sales for Omnipod in the U.S. totaled $196.4 million, representing an increase of 30.5%. Earlier this wee
Insider Monkey10 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital
In this article, we talk about the 10 best healthcare stocks to buy now according to Motley Fool’s 1623 Capital. If you wish to skip our detailed analysis of 1623 Capital’s hedge fund performance and stock picks, go directly to 5 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital. 1623 Capital […]
Insider MonkeyBillionaire Daniel Sundheim’s D1 Capital Portfolio: Top 10 Stock Picks
In this article, we discuss the top 10 stock picks of billionaire Daniel Sundheim’s D1 Capital Partners. If you want to see more top holdings of the hedge fund, check out Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 5 Stock Picks. Daniel Sundheim, the billionaire chief of D1 Capital Partners, made headlines recently as his […]
InvestorPlace7 Stocks to Buy That Could Make You a Millionaire
Recent declines on Wall Street have been unnerving for most investors. So far in the year the S&P 500 index has lost around 21%. But you can still find some interesting stocks to buy right now. Investing is a long-term strategy that helps many of us prepare for later years. Metrics suggest between 1991 and 2020, the average return for the S&P 500 index has been well over 10%. For instance, let’s assume you are now 35 with $10,000 in savings and you plan to retire at age 65. You decide to invest